Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

INTRODUCTION: Dose escalation to dominant intraprostatic lesions (DILs) is a novel method to increase the therapeutic ratio in localised prostate cancer. The Stereotactic Prostate Augmented Radiotherapy with Cyberknife (SPARC) trial was designed to determine the feasibility of a focal boost defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholls, Luke, Suh, Yae-eun, Chapman, Ewan, Henderson, Daniel, Jones, Caroline, Morrison, Kirsty, Sohaib, Aslam, Taylor, Helen, Tree, Alison, van As, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591551/
https://www.ncbi.nlm.nih.gov/pubmed/33145444
http://dx.doi.org/10.1016/j.ctro.2020.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591551/
https://www.ncbi.nlm.nih.gov/pubmed/33145444
http://dx.doi.org/10.1016/j.ctro.2020.10.004

Ejemplares similares